See also this year's filing and all EDGAR filings for this company.
PDF Report 0000109657_2018_GT_Biopharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000109657')"} |
Graph
Absolute values for 0000109657, GT Biopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 576,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,000 |
| 3 | remainder_Assets | 253,786,000 |
| 4 | LiabilitiesCurrent | 2,679,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 134,502,000 |
| 9 | ResearchAndDevelopmentExpense | 1,068,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -7,677,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 254,368,000 |
| 1 | Liabilities | 2,679,000 |
| 2 | Expenses | 135,570,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 251,689,000 |
| 5 | NetIncome | -143,247,000 |
| 6 | ComprehensiveNetIncome | -143,247,000 |
| 7 | BaseVar | 200,147,000 |
| 8 | EconomicCapitalRatio | 2.25 |
Edgar->Model Mapping
Feature Distribution
Change over Time
